‘N of 1’ therapies need a better model
Nature Medicine , Volume 27, pp 939-939; doi:10.1038/s41591-021-01380-z
Abstract: Oligonucleotides offer therapeutic potential for patients with genetic disorders carrying unique mutations, but developing individualized therapies is not supported by the current process for drug development.
Keywords: Drug development / RNA splicing / Biomedicine / general / Cancer Research / Metabolic Diseases / Infectious Diseases / Molecular Medicine / Neurosciences
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Nature Medicine" .